LABORATORY RESEARCH Identification of PTPN23 as a Novel Regulator of Cell Invasion in Mammary Epithelial Cells from a Loss-Of-Function Screen of the ‘PTP-Ome’ Scientists used an RNAi-mediated loss-of-function screen to study systematically the role of the protein tyrosine phosphatase (PTP) superfamily of enzymes in mammary epithelial cell motility in the absence or presence of the oncoprotein tyrosine kinase ERBB2. [Genes Dev] Dual Function of ERRα in Breast Cancer and Bone Metastasis Formation: Implication of VEGF and Osteoprotegerin The estrogen receptor related receptor α (ERRα) has been implicated in breast cancer and bone development, prompting researchers to examine whether ERRα may function in promoting the osteolytic growth of breast cancer cells in bone. [Cancer Res] Phosphoinositide 3-Kinase Signaling Is Critical for ErbB3-Driven Breast Cancer Cell Motility and Metastasis Investigators tested the hypothesis that ErbB3-mediated phosphoinositide 3-kinase signaling is critical for heregulin-induced motility, and therefore crucial for ErbB3-mediated invasion, intravasation and metastasis. [Oncogene] Functional Differences Among BRCA1 Missense Mutations in the Control of Centrosome Duplication This study analyzed the function of BRCA1 missense mutations in the control of centrosome duplication, a critical step in the maintenance of genetic stability of mammary epithelial cells, and indicates a new function of BRCA1 in the control of centriole pairing. [Oncogene] IQGAP1 Binds Human Epidermal Growth Factor Receptor 2 (HER2) and Modulates Trastuzumab Resistance in HER2-Positive (HER2(+)) Human Breast Cancer Researchers showed here that IQGAP1 is overexpressed in HER2(+) breast cancer tissue and binds directly to HER2. [J Biol Chem] Reduced Association of Anti-Apoptotic Protein Mcl-1 with E3 Ligase Mule Increases the Stability of Mcl-1 in Breast Cancer Cells Using human mammary epithelial and established breast cancer cell lines, investigators assessed the mechanisms that increase the stability of anti-apoptotic proteins in breast cancer cells by caspase assay, western blot, small-inhibitory RNA treatment and immunoprecipitation. [Br J Cancer] Unraveling the Antimetastatic Potential of Pentoxifylline, a Methylxanthine Derivative in Human MDA-MB-231 Breast Cancer Cells in this study, scientists have examined the effect of pentoxifylline in MDA-MB-231 human breast cancer cells. [Mol Cell Biochem] CLINICAL RESEARCH Phase I/II Study of Trastuzumab in Combination with Everolimus (RAD001) in Patients with HER2-Overexpressing Metastatic Breast Cancer Who Progressed on Trastuzumab-Based Therapy This trial evaluated the safety and efficacy of the combination of everolimus and trastuzumab in women with HER2-overexpressing metastatic breast cancer that progressed on trastuzumab-based therapy. [J Clin Oncol] Increased Risk of Locoregional Recurrence for Women with T1-2N0 Triple-Negative Breast Cancer Treated with Modified Radical Mastectomy without Adjuvant Radiation Therapy Compared with Breast-Conserving Therapy The purpose of this study was to evaluate the risk of locoregional recurrence associated with locoregional treatment of women with primary breast cancer tumors negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (triple-negative breast cancer). [J Clin Oncol] Standardization of Estrogen Receptor Measurement in Breast Cancer Suggests False-Negative Results Are a Function of Threshold Intensity Rather than Percentage of Positive Cells Researchers defined a new method for standardization of estrogen receptor measurement and then examined both change in percentage and threshold of intensity (immunoreactivity) to assess sources for test discordance. [J Clin Oncol] The Influence of Comorbidities on Overall Survival Among Older Women Diagnosed with Breast Cancer In a US population of older breast cancer patients, 13 individual comorbid conditions were associated with decreased overall survival and increased mortality. [J Natl Cancer Inst] |